Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT01886651
Eligibility Criteria:
Inclusion Criteria:
* included in the NOPHO ALL92 protocol
* available TPMT phenotype
* treated at least once with HD-MTX 5.0 g/m2 (+- 10%) during maintenance therapy
* at least one available measurement on blood counts or alanine aminotransferase levels 28 days after HD-MTX
Exclusion Criteria:
* HR ALL
* children with Down Syndrome
* Events during maintenance therapy
* TPMT deficiency
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
15 Years
Study:
NCT01886651
Study Brief:
Protocol Section:
NCT01886651